Back

Anti-fibrotic therapies for arrhythmias.

1 September 2019 (08:52 - 09:15)
Organised by:
Congress Presentation Part of: Emerging arrhythmia therapies Rhythm Control, Hybrid Therapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Dobromir Dobrev

University Hospital of Essen (Ruhr), Essen (Germany)

3 More presentations in this session

Presentation thumbnail
Gene therapy for arrhythmias.
Professor S. Priori (Pavia, IT)
Slides Video
Presentation thumbnail
Cell-cell communication in modulating arrhythmias.
Associate Professor S. Poelzing (Roanoke, US)
Slides Video
Presentation thumbnail
Optogenetics and atrial fibrillation.
Professor D. Pijnappels (Leiden, NL)

Access the full session

Session thumbnail
Emerging arrhythmia therapies

The Event

Event poster

ESC Congress 2019

1 September 2019 08:52 CET
You may be interested in
thumbnail
Congress Session
Update on antiarrhythmic therapy
31 March 2025
thumbnail
Congress Presentation
Genetic regulation of myocardial fibrosis in hypertrophic cardiomyopathy
27 August 2021
thumbnail
Congress Presentation
Pirfenidone added to standard therapy for myocardial infarction further reduces left ventricular fibrosis: a preclinical study
21 May 2022
thumbnail
Congress Presentation
The interconnected pathophysiological pathways as inflammation, fibrosis and hypercoagulation are in pathogenesis of atrial fibrillation
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources